Statement Of Cash Flows [Abstract]

Innate Pharma - Filing #2811003

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
7 570 EUR
EUR
7 570 EUR
EUR
EUR
EUR
EUR
EUR
EUR
58 103 EUR
EUR
58 103 EUR
EUR
EUR
EUR
EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for finance costs
EUR
EUR
Adjustments for unrealised foreign exchange losses (gains)
544,000 EUR
912,000 EUR
Adjustments for share-based payments
4 256 EUR
4 249 EUR
Adjustments for losses (gains) on disposal of non-current assets
470,000 EUR
EUR
Other adjustments to reconcile profit (loss)
6,000 EUR
15,000 EUR
Cash flows from (used in) operating activities
32 558 EUR
19 155 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities
150,000 EUR
EUR
Purchase of property, plant and equipment, classified as investing activities
351,000 EUR
535,000 EUR
Purchase of intangible assets, classified as investing activities
2 000 EUR
587,000 EUR
Proceeds from sales of other long-term assets, classified as investing activities
66,000 EUR
EUR
Purchase of other long-term assets, classified as investing activities
3,000 EUR
1,000 EUR
Interest received, classified as investing activities
EUR
EUR
Cash flows from (used in) investing activities
20 631 EUR
1 877 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
EUR
EUR
Interest paid, classified as financing activities
EUR
EUR
Cash flows from (used in) financing activities
1 966 EUR
1 828 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
274,000 EUR
428,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
13 619 EUR
19 532 EUR
Cash and cash equivalents
70 605 EUR
84 225 EUR
103 756 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.